Research Blog
Latest Articles
Evidence-based guides on research peptides, vendor reviews, and buyer education.
Wolverine vs. GLOW vs. KLOW: Choosing a Blend
Three pre-blended stacks, each adding one peptide to the last. Here's what actually changes between them, and what stays the same.
Read article →
Retatrutide + Cagrilintide: The Complete Research Guide
A co-formulated blend of two investigational, unapproved metabolic peptides — pairing the strongest weight-loss agonist in development with a long-acting amylin analog. Neither is FDA-approved, the combination has never been tested in a human trial, and retatrutide is the single highest-legal-risk compound we index.
Read article →
CagriSema (Cagrilintide + Semaglutide): The Complete Research Guide
The dual amylin-plus-GLP-1 combination behind Novo Nordisk's Phase 3 REDEFINE program — and the important distinction between an approved finished drug, its bulk research-grade peptide, and an unapproved co-formulation.
Read article →
Wolverine Stack: BPC-157 + TB-500 Research Guide
Why these two peptides are combined, what the literature shows for each, and what's actually established about the pair versus each compound alone.
Read article →
GLOW Blend: What GHK-Cu Adds to the Wolverine Stack
GLOW takes the Wolverine Stack's BPC-157 and TB-500 and adds a third peptide studied for a different job entirely: collagen and gene-expression research.
Read article →
KLOW Blend: What KPV Adds to GLOW
KLOW is GLOW plus a fourth peptide studied for a different pathway entirely: NF-κB inflammatory signaling and gut-lining research.
Read article →